MedPath

StrokeNet Thrombectomy Endovascular Platform

Not Applicable
Recruiting
Conditions
Ischemic Stroke
Registration Number
NCT06289985
Lead Sponsor
Medical University of South Carolina
Brief Summary

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

Detailed Description

The StrokeNet Thrombectomy Endovascular Platform (STEP) is conducted within NIH StrokeNet at 38 comprehensive stroke centers across the US. The primary goal is to optimize all aspects of care of acute ischemic stroke patients with a large or a medium vessel occlusion. The platform trial operates under an overarching Master Protocol in an inferentially integrated framework. The platform trial is designed to support the studies of three broad categories of therapeutics: expansion of endovascular treatment (EVT) indications, innovative EVT devices and concomitant medical therapies, and novel pre- and early-hospital technologies and systems of care. As new interventions are put forth, they will be added to the Master Protocol as a new Domain or part of an existing Domain. STEP utilizes a flexible Bayesian design with frequent adaptive analyses to assess whether a given intervention is superior, inferior, or equivalent either within a Domain or for specific populations within the Domain.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Global disability measured by Modified Rankin Score90-day

The modified Rankin Score is a 7-outcome ordinal scale where 0 = No symptoms and 6= Dead.

The analysis of the primary endpoint will be based on a utility weighting of the 7 outcomes, where 0 represents the worst possible health state and 1 represents the best possible state.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (41)

University of Alabama Hospital

🇺🇸

Birmingham, Alabama, United States

UCSD Health La Jolla

🇺🇸

La Jolla, California, United States

Kaiser Permanente Los Angeles Medical Center

🇺🇸

Los Angeles, California, United States

Ronald Reagan UCLA Medical Center

🇺🇸

Los Angeles, California, United States

UCSD Medical Center - Hillcrest Hospital

🇺🇸

San Diego, California, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Jackson Memorial Hospital

🇺🇸

Miami, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

Scroll for more (31 remaining)
University of Alabama Hospital
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.